Bifalgorithm post · 10 Cancer Treatment Approvals From September 2026 and What They Mean for You · 9. Lyrfigtu for FGFR2-Positive Bile Duct Cancer
Lyrfigtu Approval
Lyrfigtu Approval (10 Cancer Treatment Approvals From September 2026 and What They Mean for You · 9. Lyrfigtu for FGFR2-Positive Bile Duct Cancer) — "Lyrfigtu…
Ideas in this flowchart
- Lyrfigtu is a treatment for a specific form of cholangiocarcinoma.
- Lyrfigtu is also known as lirafugratinib.
- It is taken as a once-daily pill.
- It is used for previously treated cholangiocarcinoma.
- The tumor must have an FGFR2 fusion or rearrangement.
- Treatment outcomes
- Tumors shrank in 46% of patients.
- Responses lasted a median of 11.8 months.
